HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,650.00
-65.00 (-1.75%)
May 15, 2026, 3:30 PM KST

HLB Life Science Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
13,29152,72516,76930,97831,254
Short-Term Investments
586.8816,21211,29812,35024,690
Trading Asset Securities
-10,62950,79388,66184,017
Cash & Short-Term Investments
13,87879,56678,860131,989139,961
Cash Growth
-82.56%0.90%-40.25%-5.70%-11.44%
Accounts Receivable
14,97518,12011,46413,07211,648
Other Receivables
1,9062,0572,3712,1161,123
Receivables
22,88420,18814,64616,20214,157
Inventory
6,7916,1035,26710,8671,769
Prepaid Expenses
1,081468.69448.74208.4281.34
Other Current Assets
1,0041,382238.851,509654.91
Total Current Assets
45,637107,70999,460160,776156,822
Property, Plant & Equipment
129,75381,20672,91892,08922,081
Long-Term Investments
226,153254,694146,03844,74924,346
Goodwill
8,275-1,77221,925-
Other Intangible Assets
43,33844,78054,02969,50662,809
Long-Term Accounts Receivable
---341.17363.96
Long-Term Deferred Charges
125.91----
Other Long-Term Assets
24,67650,50049,15822,2644,262
Total Assets
478,094539,017423,500411,790270,800
Accounts Payable
2,6826,9855,1609,38410,278
Accrued Expenses
2,8192,0292,240697.15717.82
Short-Term Debt
84,72728,153106,7617,920-
Current Portion of Long-Term Debt
18,38012,2767,060387.2-
Current Portion of Leases
920.17632.14922.332,145668
Current Income Taxes Payable
177.5352.67,555132.13-
Current Unearned Revenue
-2.9131.4938.4224.01
Other Current Liabilities
9,1113,4175,7276,0811,848
Total Current Liabilities
118,81553,547135,45726,78513,536
Long-Term Debt
54,47382,52951,410136,1893,500
Long-Term Leases
1,857193.33424.01832.41452.62
Pension & Post-Retirement Benefits
709.14568.2615.57683.58716.65
Long-Term Deferred Tax Liabilities
2,2082,3103,34510,0335,758
Other Long-Term Liabilities
2,2881,0451,0361,201224.73
Total Liabilities
180,351140,192192,288175,72424,188
Common Stock
61,43261,41651,40748,83148,223
Additional Paid-In Capital
320,197319,343168,141222,910240,895
Retained Earnings
-83,41616,37310,431-40,963-46,832
Treasury Stock
-679.97-679.97-679.97--
Comprehensive Income & Other
-1821,8891,4993,9473,904
Total Common Equity
297,351398,340230,797234,725246,189
Minority Interest
390.84484.91416.211,342422.87
Shareholders' Equity
297,742398,825231,213236,067246,612
Total Liabilities & Equity
478,094539,017423,500411,790270,800
Total Debt
160,357123,783166,578147,4734,621
Net Cash (Debt)
-146,479-44,217-87,718-15,484135,340
Net Cash Growth
-----7.71%
Net Cash Per Share
-1202.14-396.21-861.84-153.361362.33
Filing Date Shares Outstanding
121.55121.81101.896.71100.44
Total Common Shares Outstanding
121.55121.81101.8101.71100.44
Working Capital
-73,17954,162-35,997133,991143,286
Book Value Per Share
2446.403270.062267.232307.672451.22
Tangible Book Value
245,738353,561174,996143,294183,380
Tangible Book Value Per Share
2021.772902.451719.071408.781825.85
Land
27,49021,56921,47129,5809,065
Buildings
51,36223,22123,22119,9504,547
Machinery
75,80540,05639,21930,94912,906
Construction In Progress
1,24333,1018,47218,3901,324
Source: S&P Global Market Intelligence. Standard template. Financial Sources.